These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 31377389

  • 1. Synthesis of novel methyl jasmonate derivatives and evaluation of their biological activity in various cancer cell lines.
    Sucu BO, Ipek OS, Kurtulus SO, Yazici BE, Karakas N, Guzel M.
    Bioorg Chem; 2019 Oct; 91():103146. PubMed ID: 31377389
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses.
    Behar V, Pahima H, Kozminsky-Atias A, Arbel N, Loeb E, Herzberg M, Becker OM.
    J Invest Dermatol; 2018 Dec; 138(12):2635-2643. PubMed ID: 29908149
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mild Alkalization Acutely Triggers the Warburg Effect by Enhancing Hexokinase Activity via Voltage-Dependent Anion Channel Binding.
    Quach CH, Jung KH, Lee JH, Park JW, Moon SH, Cho YS, Choe YS, Lee KH.
    PLoS One; 2016 Dec; 11(8):e0159529. PubMed ID: 27479079
    [Abstract] [Full Text] [Related]

  • 7. Tumor cells switch to mitochondrial oxidative phosphorylation under radiation via mTOR-mediated hexokinase II inhibition--a Warburg-reversing effect.
    Lu CL, Qin L, Liu HC, Candas D, Fan M, Li JJ.
    PLoS One; 2015 Dec; 10(3):e0121046. PubMed ID: 25807077
    [Abstract] [Full Text] [Related]

  • 8. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells.
    Elia U, Flescher E.
    Neoplasia; 2008 Nov; 10(11):1303-13. PubMed ID: 18953440
    [Abstract] [Full Text] [Related]

  • 9. Methyl jasmonate: a plant stress hormone as an anti-cancer drug.
    Cohen S, Flescher E.
    Phytochemistry; 2009 Sep; 70(13-14):1600-9. PubMed ID: 19660769
    [Abstract] [Full Text] [Related]

  • 10. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V, Ben-Hail D, Admoni L, Krelin Y, Tripathi SS.
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [Abstract] [Full Text] [Related]

  • 11. Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.
    Krasnov GS, Dmitriev AA, Lakunina VA, Kirpiy AA, Kudryavtseva AV.
    Expert Opin Ther Targets; 2013 Oct; 17(10):1221-33. PubMed ID: 23984984
    [Abstract] [Full Text] [Related]

  • 12. Isolation of the four methyl jasmonate stereoisomers and their effects on selected chiral volatile compounds in red raspberries.
    Flores G, Blanch GP, Ruiz del Castillo ML.
    Food Chem; 2013 Dec 01; 141(3):2982-7. PubMed ID: 23871049
    [Abstract] [Full Text] [Related]

  • 13. Voltage-dependent anion channel 1-based peptides interact with hexokinase to prevent its anti-apoptotic activity.
    Arzoine L, Zilberberg N, Ben-Romano R, Shoshan-Barmatz V.
    J Biol Chem; 2009 Feb 06; 284(6):3946-55. PubMed ID: 19049977
    [Abstract] [Full Text] [Related]

  • 14. Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy.
    Mathupala SP, Ko YH, Pedersen PL.
    Semin Cancer Biol; 2009 Feb 06; 19(1):17-24. PubMed ID: 19101634
    [Abstract] [Full Text] [Related]

  • 15. Design and production of methyl jasmonate nanoemulsions using experimental design technique and evaluation of its anti-cancer efficacy.
    Habibi K, Sepehri H, Delphi L, Mirjalili MH, Rafati H.
    Pharmazie; 2017 Nov 01; 72(11):652-662. PubMed ID: 29442039
    [Abstract] [Full Text] [Related]

  • 16. New jasmonate analogues as potential anti-inflammatory agents.
    Dang HT, Lee HJ, Yoo ES, Hong J, Bao B, Choi JS, Jung JH.
    Bioorg Med Chem; 2008 Dec 15; 16(24):10228-35. PubMed ID: 18996699
    [Abstract] [Full Text] [Related]

  • 17. Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose.
    Heyfets A, Flescher E.
    Cancer Lett; 2007 Jun 08; 250(2):300-10. PubMed ID: 17125916
    [Abstract] [Full Text] [Related]

  • 18. VDAC electronics: 1. VDAC-hexo(gluco)kinase generator of the mitochondrial outer membrane potential.
    Lemeshko VV.
    Biochim Biophys Acta; 2014 May 08; 1838(5):1362-71. PubMed ID: 24412217
    [Abstract] [Full Text] [Related]

  • 19. New Amino Acid Schiff Bases as Anticancer Agents via Potential Mitochondrial Complex I-Associated Hexokinase Inhibition and Targeting AMP-Protein Kinases/mTOR Signaling Pathway.
    Noser AA, Abdelmonsef AH, El-Naggar M, Salem MM.
    Molecules; 2021 Sep 02; 26(17):. PubMed ID: 34500765
    [Abstract] [Full Text] [Related]

  • 20. Jasmonates--a new family of anti-cancer agents.
    Flescher E.
    Anticancer Drugs; 2005 Oct 02; 16(9):911-6. PubMed ID: 16162967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.